CriSNPr, a single interface for the curated and de novo design of gRNAs for CRISPR diagnostics using diverse Cas systems
eLife · 2023
DOI: 10.7554/elife.77976 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Asgar H Ansari und 4 weiteren Autor:innen. Beteiligte Einrichtung: CSIR-Institute of Genomics & Integrative Biology, New Delhi, India. Hauptthemen laut MEDLINE: COVID-19, CRISPR-Cas Systems, RNA, Guide, CRISPR-Cas Systems. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EMBO, Lady Tata Memorial Trust, CSIR-Sickle Cell Mission.
Abstract (Originalsprache)
CRISPR-based diagnostics (CRISPRDx) have improved clinical decision-making, especially during the COVID-19 pandemic, by detecting nucleic acids and identifying variants. This has been accelerated by the discovery of new and engineered CRISPR effectors, which have expanded the portfolio of diagnostic applications to include a broad range of pathogenic and non-pathogenic conditions. However, each diagnostic CRISPR pipeline necessitates customized detection schemes based on the fundamental principles of the Cas protein used, its guide RNA (gRNA) design parameters, and the assay readout. This is especially relevant for variant detection, a low-cost alternative to sequencing-based approaches for which no in silico pipeline for the ready-to-use design of CRISPRDx currently exists. In this manuscript, we fill this lacuna using a unified web server, CriSNPr (CRISPR-based SNP recognition), which provides the user with the opportunity to de novo design gRNAs based on six CRISPRDx proteins of choice ( Fn /en Fn Cas9, Lw Cas13a, Lb Cas12a, Aa Cas12b, and Cas14a) and query for ready-to-use oligonucleotide sequences for validation on relevant samples. Furthermore, we provide a database of curated pre-designed gRNAs as well as target/off-target for all human and SARS-CoV-2 variants reported thus far. CriSNPr has been validated on multiple Cas proteins, demonstrating its broad and immediate applicability across multiple detection platforms. CriSNPr can be found at http://crisnpr.igib.res.in/ .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CSIR-Institute of Genomics & Integrative Biology, New Delhi, India.
- Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, India.
ORCID-Profile: Asgar H Ansari, Manoj Kumar, Debojyoti Chakraborty
Förderung
- EMBO
- Lady Tata Memorial Trust
- CSIR-Sickle Cell Mission
Zitieren
APA
Ansari, A. H., Kumar, M., Sarkar, S., Maiti, S., & Chakraborty, D. (2023). CriSNPr, a single interface for the curated and de novo design of gRNAs for CRISPR diagnostics using diverse Cas systems. eLife. https://doi.org/10.7554/elife.77976
Vancouver
Ansari AH, Kumar M, Sarkar S, Maiti S, Chakraborty D. CriSNPr, a single interface for the curated and de novo design of gRNAs for CRISPR diagnostics using diverse Cas systems. eLife. 2023. doi:10.7554/elife.77976
BibTeX
@article{Ansari2023,
author = {Ansari, Asgar H and Kumar, Manoj and Sarkar, Sajal and Maiti, Souvik and Chakraborty, Debojyoti},
title = {CriSNPr, a single interface for the curated and de novo design of gRNAs for CRISPR diagnostics using diverse Cas systems},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.77976}
}
EUVIMED